Overall Learning Objectives
At the end of this meeting, participants will be able to:
- Identify concepts, facilitate collaboration and satisfy personal education goals in the field of cardiac arrhythmias from leading Canadian and International experts. (Medical Expert, Collaborator, Scholar, Leader)
- Apply the latest advances in the field of cardiac arrhythmias, including cardiac implantable electronic devices, inherited arrhythmic disorders, insights in ventricular fibrillation and technologies in VT ablation. (Medical Expert, Collaborator, Scholar, Leader)
- Demonstrate a balanced perspective on prevention and management of cardiac arrhythmias from a field of experts including clinician experts, clinician researchers, basic scientists, and allied health professionals. (Medical Expert, Collaborator, Scholar, Leader)
Session Specific Learning Objectives
Friday September 12, 2025
SESSION 1: FELLOWS & ALLIED HEALTH PROFESSIONAL PROGRAM
Following this session, participants will be able to:
- Develop an approach to left bundle area pacing, lead extraction and SVT. (Medical Expert, Collaborator, Scholar, Leader)
- Participate in Fellows Case Presentations sessions addressing basic and advanced concepts in the field of cardiac arrhythmias. (Medical Expert, Collaborator, Scholar, Leader)
Saturday September 13, 2025
SESSION 1: ICDs (Joint Session HRS/CHRS)
Following this session, participants will be able to:
- Identify the patients’ different arrhythmic conditions where a driving restriction must be applied. (Medical Expert, Collaborator, Scholar, Leader)
- Synthesize the current evidence regarding the role of primary prevention ICDs in patients with NICMP. (Medical Expert, Collaborator, Scholar, Leader)
- Distinguish frailty screening from frailty assessment and understand degrees of frailty. (Medical Expert, Collaborator, Scholar, Leader)
SESSION 2: LBB
Following this session, participants will be able to:
- Recognize the indication of CSP vs CRT indication in HF patients and identify the place of the CSP in CIEDs indication. (Medical Expert, Collaborator, Scholar, Leader)
- Describe the new technologies available in 2025 to implant LBBA-ICD and leadless LBB pacemaker. (Medical Expert, Collaborator, Scholar, Leader)
- Identify the different technic for CIEDs-LBBA implant. (Medical Expert, Collaborator, Scholar, Leader)
SESSION 3: PEDIATRIC-CONGENITAL
Following this session, participants will be able to:
- Identify the high-risk patients with a pathway who should be referred and ablated. (Medical Expert, Collaborator, Scholar, Leader)
- Understand newer pacing and defibrillation modalities in children. (Medical Expert, Collaborator, Scholar, Leader)
- Recognize when to refer young patients in a context of family history of cardiogenetic syndrome. (Medical Expert, Collaborator, Scholar, Leader)
SESSION 5: VT-VF ABLATION (Joint Session EHRA/CHRS)
Following this session, participants will be able to:
- Recognize the best timing to propose a VT ablation to ischemic patients with an indication of VT ablation. (Medical Expert, Collaborator, Scholar, Leader)
- Identify new insights and availabilities for VF management in term of ablation. (Medical Expert, Collaborator, Scholar, Leader)
- Apply the new technologies available in VT ablation in 2025. (Medical Expert, Collaborator, Scholar, Leader)